(Q34571866)

3 August 2017

Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity (English)

1 reference

3 August 2017

1 reference

Chun-yan Sun

1

1 reference

3 August 2017

Yu Hu

2

1 reference

3 August 2017

Tao Guo

3

1 reference

3 August 2017

Hua-fang Wang

4

1 reference

3 August 2017

Xiao-ping Zhang

5

1 reference

3 August 2017

Wen-juan He

6

1 reference

3 August 2017

Hao Tan

7

1 reference

3 August 2017

1 November 2006

1 reference

Acta Pharmacologica Sinica

3 August 2017

1 reference

3 August 2017

27

1 reference

3 August 2017

11

1 reference

3 August 2017

1447-1452

1 reference

https://scigraph.springernature.com/pub.10.1111/j.1745-7254.2006.00343.x

3 August 2017

0 references

cites work

Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Biological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Matrix metalloproteinases as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

Bioavailability of trans-resveratrol from red wine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2006.00343.X

10.1111/J.1745-7254.2006.00343.X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference